Stocks and Investing Stocks and Investing
Thu, May 18, 2023

Mason Carrico Reiterated (TXG) at Buy and Held Target at $65 on, May 18th, 2023


Published on 2024-10-28 03:52:28 - WOPRAI, Mason Carrico
  Print publication without navigation


Mason Carrico of Stephens & Co., Reiterated "10x Genomics, Inc." (TXG) at Buy and Held Target at $65 on, May 18th, 2023.

Mason has made no other calls on TXG in the last 4 months.



There are 6 other peers that have a rating on TXG. Out of the 6 peers that are also analyzing TXG, 1 agrees with Mason's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • John Sourbeer of "UBS" Initiated at Hold and Held Target at $50 on, Thursday, February 2nd, 2023


These are the ratings of the 5 analyists that currently disagree with Mason


  • Luke Sergott of "Barclays" Initiated at Buy and Held Target at $65 on, Wednesday, May 10th, 2023
  • Dan Brennan of "TD Cowen" Maintained at Buy with Increased Target to $66 on, Thursday, May 4th, 2023
  • Daniel Arias of "Stifel" Maintained at Strong Buy with Increased Target to $68 on, Thursday, May 4th, 2023
  • Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $65 on, Thursday, May 4th, 2023
  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $65 on, Thursday, February 16th, 2023
Contributing Sources